- Trials with a EudraCT protocol (131)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
131 result(s) found for: Nervous System Diseases AND Spinal Cord Diseases.
Displaying page 1 of 7.
| EudraCT Number: 2012-005328-14 | Sponsor Protocol Number: SATIVEX-2013 | Start Date*: 2013-04-16 | |||||||||||||||||||||
| Sponsor Name:Spinal Cord Injury Centre of Western Denmark | |||||||||||||||||||||||
| Full Title: Effect of Sativex on neuropathic pain and spasticity following spinal cord injury | |||||||||||||||||||||||
| Medical condition: Neuropathic pain and spasticity following spinal cord injury | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: DK (Prematurely Ended) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2012-002211-25 | Sponsor Protocol Number: bot001 | Start Date*: 2013-04-08 |
| Sponsor Name:Oslo University Hospital, Dept of Urology | ||
| Full Title: Prevention of bladder dysfunction in acute spinal cord injury A double-blind, randomized, placebo-controlled study to explore the effect of early treatment with Onabotulinumtoxin A in patients ... | ||
| Medical condition: Bladder dysfunction after acute spinal cord injury | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NO (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-003197-57 | Sponsor Protocol Number: A0081181 | Start Date*: 2012-11-09 | ||||||||||||||||||||||||||||||||||||
| Sponsor Name:Pfizer Worldwide Research and Development | ||||||||||||||||||||||||||||||||||||||
| Full Title: A MULTIPLE DOSE PHARMACOKINETIC OPEN-LABEL STUDY OF PREGABALIN (LYRICA) IN HEALTHY LACTATING WOMEN | ||||||||||||||||||||||||||||||||||||||
| Medical condition: neuropathic pain associated with diabetic peripheral neuropathy postherpetic neuralgia neuropathic pain related to spinal cord injury (US), fibromyalgia (US, JP) treatment of central and periphe... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
| Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||||||||||||
| Trial protocol: BE (Completed) | ||||||||||||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2014-002170-36 | Sponsor Protocol Number: 2014-002170-36 | Start Date*: 2015-02-11 |
| Sponsor Name:Karolinska University Hospital | ||
| Full Title: Treatment of Cervical Spinal Cord Injury with Imatinib – a safety and feasibility study | ||
| Medical condition: Cervical Spinal Cord Injury | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-001227-31 | Sponsor Protocol Number: NISCI | Start Date*: 2019-06-19 | ||||||||||||||||
| Sponsor Name:University Zurich, University Hospital Balgrist, Spinal Cord Injury Center | ||||||||||||||||||
| Full Title: Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury | ||||||||||||||||||
| Medical condition: spinal cord injury | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) CZ (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2015-005717-80 | Sponsor Protocol Number: FAB117-CT-01 | Start Date*: 2016-05-29 | ||||||||||||||||
| Sponsor Name:Ferrer Internacional S.A | ||||||||||||||||||
| Full Title: Clinical trial of phase 1/2 to evaluate the feasibility, safety, tolerability and preliminary efficacy of the administration of FAB117-HC, a drug whose active ingredient is HC016, allogeneic adipos... | ||||||||||||||||||
| Medical condition: Patients with acute traumatic spinal cord injury | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: ES (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2011-005684-24 | Sponsor Protocol Number: CME-LEM2 | Start Date*: 2014-01-16 | |||||||||||
| Sponsor Name:Fundación Investigación Biomédica Hospital Universitario Puerta de Hierro | |||||||||||||
| Full Title: Subarachnoid administration of autologous bone marrow stromal cells in incomplete spinal cord injury. | |||||||||||||
| Medical condition: Incomplete spinal cord injury, due to traumatical or ischemic cause. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2015-005786-23 | Sponsor Protocol Number: XCEL-SCI-01 | Start Date*: 2016-04-20 | |||||||||||
| Sponsor Name:Banc de Sang i Teixits | |||||||||||||
| Full Title: A phase I/IIa, randomized, double-blind, single-dose, placebo controlled, two-way crossover clinical trial to assess the safety and to obtain efficacy data in intrathecal administration of expanded... | |||||||||||||
| Medical condition: Chronic traumatic spinal cord injury | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-000346-18 | Sponsor Protocol Number: BST-SCI-02 | Start Date*: 2021-06-28 | |||||||||||
| Sponsor Name:Banc de Sang i Teixits | |||||||||||||
| Full Title: A phase I/II, randomized, double-blind, placebo-controlled, parallel, 2-arms clinical trial to assess the safety and efficacy of intrathecal administration of WJ-MSC in chronic traumatic cervical i... | |||||||||||||
| Medical condition: Cronic traumatic spinal cord injury | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-002177-35 | Sponsor Protocol Number: GNB-2015 | Start Date*: 2018-05-07 |
| Sponsor Name:Masarykova univerzita | ||
| Full Title: The effect of gabapentin used as a preemptive to the emergence and development chronic neuropathic pain in patients after spinal cord trauma | ||
| Medical condition: Chronic neuropathic pain in patients after spinal cord trauma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: CZ (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-003752-36 | Sponsor Protocol Number: M16-077 | Start Date*: 2020-05-14 | |||||||||||
| Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
| Full Title: A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Traumatic Cervical Spinal Cord Injury | |||||||||||||
| Medical condition: Spinal cord injury (SCI) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-005613-24 | Sponsor Protocol Number: CME-LEM3 | Start Date*: 2015-06-19 |
| Sponsor Name:Fundación Investigación Biomédica Hospital Universitario Puerta de Hierro | ||
| Full Title: Intrathecal administration (pattern 100/3) of expanded autologous adult bone marrow mesenchymal troncal cells in established chronic spinal cord injuries | ||
| Medical condition: Traumatic or ischemic spinal cord injury, chronically established and considered irreversible | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2013-000906-52 | Sponsor Protocol Number: SC0806-A101 | Start Date*: 2015-03-24 |
| Sponsor Name:BioArctic AB | ||
| Full Title: An Open, Randomized, Rehabilitation-controlled Study to Assess Safety, Tolerability, and Efficacy of Heparin Activated Recombinant Human Fibroblast Growth Factor 1 on a Biodegradable Device in Subj... | ||
| Medical condition: Complete Traumatic Spinal Cord Injury (TSCI) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Prematurely Ended) NO (Completed) EE (Prematurely Ended) FI (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-000975-10 | Sponsor Protocol Number: CME-LEM5 | Start Date*: 2017-09-25 |
| Sponsor Name:Fundación Investigación Biomédica Hospital Universitario Puerta de Hierro Majadahonda | ||
| Full Title: Intrathecal administration of bone marrow adult autologous stem mesenchymal cells expanded in chronically established low injuries of the spinal cord | ||
| Medical condition: Traumatic or ischemic spinal cord injury, chronically established and considered irreversible | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-002383-16 | Sponsor Protocol Number: CME-LEM4 | Start Date*: 2016-01-19 |
| Sponsor Name:Fundación Investigación Biomédica Hospital Universitario Puerta de Hierro | ||
| Full Title: Evaluate the efficacy of the cell therapy with NC1 medication in patients with post-traumatic syringomyelia | ||
| Medical condition: Traumatic spinal cord injury, chronically established, associated with syringomyelia and neurological deficit considered irreversible. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2022-001777-31 | Sponsor Protocol Number: IG2021370 | Start Date*: 2023-05-08 |
| Sponsor Name:Hospital de Neurorrehabilitación Institut Guttmann | ||
| Full Title: Pilot study on the effect of cannabinoids THC + CBD on resistant spasticity in patients with chronic spinal cord injury. | ||
| Medical condition: Pilot study on the effect of THC+CBD cannabinoids on resistant spasticity in patients with chronic spinal cord injury. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-002592-29 | Sponsor Protocol Number: MIR-2014 | Start Date*: 2015-04-17 |
| Sponsor Name:Fakultní nemocnice Ostrava | ||
| Full Title: A randomized, double blind, placebo controlled study to evaluate the efficacy and safety of mirabegron 50 mg versus placebo in patients with neurogenic detrusor overactivity | ||
| Medical condition: Spinal cord injury Multiple sclerosis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: CZ (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-006503-15 | Sponsor Protocol Number: STA-LDH01 | Start Date*: 2023-02-23 | |||||||||||||||||||||
| Sponsor Name:Stayble Therapeutics | |||||||||||||||||||||||
| Full Title: A prospective, randomised, double-blinded, placebo-controlled study investigating the safety and tolerability of STA363 in patients with radiculopathy caused by lumbar disc herniation | |||||||||||||||||||||||
| Medical condition: Radiculopathy due to lumbar intervertebral disc herniation | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: PL (Completed) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2021-004994-30 | Sponsor Protocol Number: NL68837.091.21 | Start Date*: 2022-02-08 |
| Sponsor Name:Roessingh | ||
| Full Title: Pulmonary function and sleep related disorders during cervical admission of intrathecal baclofen in spinal cord injury; a safety study | ||
| Medical condition: Spasticity in patients with spinal cord injury | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-002315-98 | Sponsor Protocol Number: MedicalcannabisMSSCI2018 | Start Date*: 2018-12-06 | ||||||||||||||||
| Sponsor Name:Aarhus Universitetshospital | ||||||||||||||||||
| Full Title: The effect of medical cannabis on neuropathic pain and spasticity in patients with Multiple Sclerosis and in patients with spinal cord injury. A multicenter national placebo-controlled trial | ||||||||||||||||||
| Medical condition: Central neuropathic pain and spasticity | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DK (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.